At SEA × US Founder Night I learned that strategic capital takes timing and clarity, and storytelling takes consistency.
I felt an urgency to learn from the giants of science while they are still here, so I acted boldly and applied.
I'm developing AI-powered autoimmune flare prediction from wearable health data, in stealth.
At NUS I ran immune-metabolic research with qPCR and redox assays, with teams from SIgN and A*STAR.
I helped design methods for analyzing cell-cell interactions using 10X Genomics data.
I'm a founder-in-progress at NYU, building Flareheal, an AI tool for autoimmune flare prediction.
At SEA × US Founder Night I learned that strategic capital takes timing and clarity, and storytelling takes consistency.
I felt an urgency to learn from the giants of science while they are still here, so I acted boldly and applied.
I'm developing AI-powered autoimmune flare prediction from wearable health data, in stealth.
At NUS I ran immune-metabolic research with qPCR and redox assays, with teams from SIgN and A*STAR.
I helped design methods for analyzing cell-cell interactions using 10X Genomics data.
I'm a founder-in-progress at NYU, building Flareheal, an AI tool for autoimmune flare prediction.
At SEA × US Founder Night I learned that strategic capital takes timing and clarity, and storytelling takes consistency.
I felt an urgency to learn from the giants of science while they are still here, so I acted boldly and applied.
I'm developing AI-powered autoimmune flare prediction from wearable health data, in stealth.
At NUS I ran immune-metabolic research with qPCR and redox assays, with teams from SIgN and A*STAR.
I helped design methods for analyzing cell-cell interactions using 10X Genomics data.
By using this service, you agree to the Terms of Service and Privacy Policy.